Local delivery of green tea catechins inhibits neointimal formation in the rat carotid artery injury model

Heart and Vessels

Volumn 19, Issue 5, 2004, Pages 242-247

  Kim, Dong Woon ^a   Park, Young Sun ^a   Kim, Young Gyu ^a   Piao, Hainan ^a   Kwon, Jin Sook ^a   Hwang, Kyung Kuk ^a   Youn, Tae Jin ^a   Park, Jong Bum ^b   Yun, Yeo Pyo ^c   Sachinidis, Agapios ^d   Kim, Chan Hyung ^a   Cho, Myeong Chan ^a   Ahn, Hee Yul ^a  

^a Chungbuk National University College of Medicine   (South Korea)

^b Sama Pharmaceutical Company   (South Korea)

^c Chungbuk National University   (South Korea)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Angioplasty; Catechin; Restenosis

Indexed keywords

CATECHIN; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; PLATELET DERIVED GROWTH FACTOR BB; THYMIDINE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERIOGRAPHY; CAROTID ARTERY; CAROTID ARTERY INJURY; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG MECHANISM; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

ANGIOGRAPHY; ANGIOPLASTY; ANIMALS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CATECHIN; CELL PROLIFERATION; CORONARY RESTENOSIS; ENZYMES; MALE; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, INBRED F344; RECOMBINANT PROTEINS; TEA; TUNICA INTIMA;

EID: 5044230087     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-004-0768-6     Document Type: Article

References (20)

1. Gottsauner-Wolf M, Moliterno DJ, Lincoff AM, Topol EJ (1996) Restenosis - an open file. Clin Cardiol 19:347-356
2. Popma JJ, Califf RM, Topol EJ (1991) Clinical trials of restenosis after coronary angioplasty. Circulation 84:1426-1436
3. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel M-A, for the BENESTENT Study Group (1994) A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 331:489-495
4. Edelman ER, Rogers C (1996) Hoop dreams: stents without restenosis. Circulation 94:1199-1202
5. 32P radioactive β-emitting stent implantation in patients with coronary artery disease. The Milan dose-response study. Circulation 101:18-26
6. Costa MA, Sabaté M, van der Giessen WJ, Kay IP, Cervinka P, Ligthart JMR, Serrano P, Coen VLMA, Levendag PC, Serruys PW (1999) Late coronary occlusion after intracoronary brachytherapy. Circulation 100:789-792
7. Sollott SJ, Cheng L, Pauly RR, Jenkins GM, Monticone RE, Kuzuya M, Froehlich JP, Crow MT, Lakatta EG, Rowinsky EK, Kinsella JL (1995) Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest 95:1869-1876
8. Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A, Wild DH, Brehm BR, Riessen R, Koveker G, Karsch KR (1997) Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96:636-645
9. Jankun J, Selman SH, Swiercz R, Skrzypczak-Jankun E (1997) Why drinking green tea could prevent cancer. Nature 387:567
10. Sachinidis A, Seul C, Seewald S, Ahn HY, Ko Y, Vetter H (2000) Green tea compounds inhibit tyrosine phosphorylation of PDGF β-receptor and transformation of A172 human glioblastoma. FEBS Lett 471:51-55
11. Cao Y, Cao R (1999) Angiogenesis inhibited by drinking tea. Nature 398:381
12. Hara Y, Tono-Oka F (1990) Hypotensive effect of tea catechins on blood pressure of rats. J Jpn Soc Nutr Food Sci 43:345-348
13. Matsumoto N, Ishigaki F, Ishigaki A, Iwashina H, Hara Y (1993) Reduction of blood glucose levels by tea catechin. Biosci Biotech Biochem 57:525-527
14. Muramatsu K, Fukuyo M, Hara Y (1986) Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol 32:613-622
15. Lu LH, Lee SS, Huang HC (1998) Epigallocatechin suppression of proliferation of vascular smooth muscle cells: correlation with c-jun and JNK. Br J Pharmacol 124:1227-1237
16. Ahn HY, Hadizadeh KR, Seul Claudia, Yun YP, Vetter H, Sachinidis A (1999) Epigallocatechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol Biol Cell 10:1093-1104
17. 2 and vascular smooth muscle cell proliferation. Hypertension 26:771-780
18. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
19. Clowes AW, Reidy MA, Clowes MM (1983) Kinetics of cellular proliferation after arterial injury: I. Smooth muscle growth in the absence of endothelium. Lab Invest 49:327-333
20. Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Sirkin K, Cloutier DA, Leon MB, Tripuraneni P (2000) Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 101:360-365